| Trade name of the product: |
| Rifater |
| Pharmaceutical active ingredients: |
| IsoniazidPyrazinamideRifampin |
| Available forms, composition and doses of Rifater: |
| Dragee; Oral; Isoniazid 75 mg; Pyrazinamide 400 mg; Rifampin 150 mgTablets, Film-Coated; Oral; Isoniazid 50 mg; Pyrazinamide 300 mg; Rifampin 120 mgTablets; Oral; Isoniazid 50 mg; Pyrazinamide 300 mg; Rifampin 120 mgTablets; Oral; Isoniazid 80 mg; Pyrazinamide 250 mg; Rifampin 120 mg |
| Medical categories: |
| Human:Antituberculosis agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J04AM05 - Rifampicin, Pyrazinamide and Isoniazid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisDKSHDuncan PharmaceuticalsFour StarGrunenthalIDS GroupZuellig Pharma |
| Related documents and information about Rifater: |
| Rifater prescribing information (PDF) |